SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 325.64 |
| Book Value / Share | 0.05 |
| Price / Book | n/a |
| NCAV ($M) | 126.87 |
| NCAV / Share | 0.02 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.19 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 0.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.31 |
| Current Ratio | 2.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 318.78 |
| Assets | 517.55 |
| Liabilities | 191.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 552.98 |
| Operating Income | 101.90 |
| Net Income | 82.77 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 66.71 |
| Cash from Investing | -168.07 |
| Cash from Financing | 27.79 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| TRVN – Trevena, Inc. | TSMRF – Tsumura & Co. |
| UCBJF – UCB SA | VAXX – Vaxxinity, Inc. |
| VCNX – Vaccinex, Inc. |
Financial data and stock pages provided by
Fintel.io